Sudeep Pharma Limited has announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a total income of ₹20,268.34 lakhs for the quarter and a profit of ₹5,181.11 lakhs. The results reflect the performance of the group, including its subsidiaries, prepared in accordance with Indian Accounting Standard 34.
Sudeep Pharma Announces Q2 FY27 Financial Results
Sudeep Pharma Limited has disclosed its unaudited consolidated financial results for the quarter and half-year ending September 30, 2026. The Board of Directors reviewed and approved these results during their meeting held on October 28, 2026.
Quarterly Financial Highlights
For the quarter ended September 30, 2026, Sudeep Pharma reported a total income of ₹20,268.34 lakhs. The company’s profit before tax stood at ₹7,103.25 lakhs, and after accounting for tax expenses of ₹1,922.14 lakhs, the profit for the period (net profit) was ₹5,181.11 lakhs.
The total comprehensive income for the quarter attributable to the owners of the group was ₹5,123.01 lakhs. The company’s Earnings Per Equity Share (Basic and Diluted) for the quarter was ₹4.59.
Year-to-Date Performance
For the half-year ended September 30, 2026, the total income was ₹36,639.93 lakhs. Profit before tax for this period reached ₹12,532.51 lakhs, with a net profit of ₹9,239.80 lakhs after tax expenses of ₹3,292.71 lakhs.
Total comprehensive income for the half-year attributable to owners of the group was ₹9,172.80 lakhs. The Earnings Per Equity Share (Basic and Diluted) for the half-year stood at ₹8.18.
Balance Sheet Overview
As of September 30, 2026, the company’s total assets amounted to ₹1,32,862.70 lakhs. The total equity stood at ₹97,282.93 lakhs, while total liabilities were ₹35,579.77 lakhs.
Cash Flow Statement Insights
The unaudited consolidated statement of cash flows for the period ended September 30, 2026, shows net cash generated from operating activities amounting to ₹4,350.31 lakhs. Investing activities resulted in a net cash used of ₹3,285.56 lakhs, and financing activities generated a net cash of ₹1,612.38 lakhs. The net increase in cash and cash equivalents for the period was ₹2,677.13 lakhs.
Source: BSE
